3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
70
Burkitt Lymphoma
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia, Biphenotypic, Acute
14
Myelodysplastic Syndromes
12
Leukemia
9
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Sarcoma, Myeloid
4
Recurrence
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Blast Crisis
4
Leukemia, Monocytic, Acute
3
Hematologic Neoplasms
3
Down Syndrome
3
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Targeted Therapy
1
Interventions
empagliflozin
1
Social Determinants of Health
1
Environmental Biomarkers
1
Echocardiography
1
Carvedilol
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Cytarabine
×
90 days
×
Clear all
No trials found.